9 Signs You're a Automated Compounding Systems Expert
The North America automated compounding systems 
market is expected to reach US$ 339.69 millionby 2027 from US$ 197.53 million in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020 to 2027.
The automated compounding systemsmarketis growing primarily due to the growing adoption of chemotherapy, personalized medication, and rising need to minimize medication errors in the North America region. High cost of the automated compounding systems and COVID-19 pandemicare likely to restrain the growth of the market in coming years. Additionally, increasing awareness about automated compounding systemsamong pharmacistsand introduction of novel robotic technology automation in compounding systemsare likely to increase the growth of the automated compounding systems marketduring the forecast period.
Get PDF Brochure: https://bit.ly/2WqmJZZ
\
Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from their regular supply of automated compounding systems. Majority of the companies which are operating in the manufacturing segment of automated compounding systems products are currently working on Personal Protective Equipment (PPE), such as gloves, masks, and gowns. In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases. The COVID-19 outbreak highlights potential vulnerabilities in both our drug supply chain and clinical infrastructure, including the availability of adequate clinician resources.
market is expected to reach US$ 339.69 millionby 2027 from US$ 197.53 million in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020 to 2027.The automated compounding systemsmarketis growing primarily due to the growing adoption of chemotherapy, personalized medication, and rising need to minimize medication errors in the North America region. High cost of the automated compounding systems and COVID-19 pandemicare likely to restrain the growth of the market in coming years. Additionally, increasing awareness about automated compounding systemsamong pharmacistsand introduction of novel robotic technology automation in compounding systemsare likely to increase the growth of the automated compounding systems marketduring the forecast period.
Get PDF Brochure: https://bit.ly/2WqmJZZ
\Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from their regular supply of automated compounding systems. Majority of the companies which are operating in the manufacturing segment of automated compounding systems products are currently working on Personal Protective Equipment (PPE), such as gloves, masks, and gowns. In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases. The COVID-19 outbreak highlights potential vulnerabilities in both our drug supply chain and clinical infrastructure, including the availability of adequate clinician resources.
Comments
Post a Comment